Assisted Reproductive Technology Market: Trends, Growth, and Insights

The global Assisted Reproductive Technology (ART) market plays a crucial role in addressing infertility, which affects millions worldwide due to factors like STIs, PCOS, endometriosis, and POI. According to WHO, one in six individuals faces infertility, driving ART's rapid growth. ART includes IVF, artificial insemination, and egg freezing, providing hope for many. In 2024, the ART market was valued at USD 23.54 billion and is projected to exceed USD 44 billion by 2034 at a 6.50% CAGR. North America and Europe lead, while Asia-Pacific sees the fastest growth due to rising adoption and medical tourism.